These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 32730361)

  • 21. A new clinical prognostic nomogram for liver cancer based on immune score.
    Shen Q; Hu G; Wu J; Lv L
    PLoS One; 2020; 15(7):e0236622. PubMed ID: 32730361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic nomogram based on immune scores for breast cancer patients.
    Wang J; Li Y; Fu W; Zhang Y; Jiang J; Zhang Y; Qi X
    Cancer Med; 2019 Sep; 8(11):5214-5222. PubMed ID: 31342666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Prognostic Nomogram Based on Immune Scores Predicts Postoperative Survival for Patients with Hepatocellular Carcinoma.
    Wang J; Zhang C; Li A; Cao F; Liu D; Li F; Luo T
    Biomed Res Int; 2020; 2020():1542394. PubMed ID: 32724794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer.
    Qi X; Fu Y; Zhang M; Lu C; Wang Y; Peng J; Li G
    Biomed Res Int; 2020; 2020():8882576. PubMed ID: 33224983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study.
    Huang JF; Chen D; Sang CM; Zheng XQ; Lin JL; Lin Y; Ni WF; Wang XY; Li YM; Wu AM
    World Neurosurg; 2019 Aug; 128():e603-e614. PubMed ID: 31054340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-103 promotes hepatocellular carcinoma cell proliferation and migration in the simulation transition zone of RFA through PI3K/Akt signaling pathway by targeting PTEN.
    Tan Y; Zhao L
    Int J Clin Exp Pathol; 2020; 13(3):473-479. PubMed ID: 32269684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poor clinical outcome in metastatic melanoma is associated with a microRNA-modulated immunosuppressive tumor microenvironment.
    Jorge NAN; Cruz JGV; Pretti MAM; Bonamino MH; Possik PA; Boroni M
    J Transl Med; 2020 Feb; 18(1):56. PubMed ID: 32024530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular components in tumor microenvironment of neuroblastoma and the prognostic value.
    Zhong X; Zhang Y; Wang L; Zhang H; Liu H; Liu Y
    PeerJ; 2019; 7():e8017. PubMed ID: 31844563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis.
    Bie Y; Ge W; Yang Z; Cheng X; Zhao Z; Li S; Wang W; Wang Y; Zhao X; Yin Z; Li Y
    Dis Markers; 2019; 2019():8023460. PubMed ID: 31827643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential Biomarkers.
    Tai D; Choo SP; Chew V
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31816940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
    Longo V; Brunetti O; Gnoni A; Licchetta A; Delcuratolo S; Memeo R; Solimando AG; Argentiero A
    Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31627433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune cell infiltration as a biomarker for the diagnosis and prognosis of digestive system cancer.
    Yang S; Liu T; Cheng Y; Bai Y; Liang G
    Cancer Sci; 2019 Dec; 110(12):3639-3649. PubMed ID: 31605436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies.
    Cheng H; Sun G; Chen H; Li Y; Han Z; Li Y; Zhang P; Yang L; Li Y
    Am J Cancer Res; 2019; 9(8):1536-1545. PubMed ID: 31497341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis.
    Yau T; Hsu C; Kim TY; Choo SP; Kang YK; Hou MM; Numata K; Yeo W; Chopra A; Ikeda M; Kuromatsu R; Moriguchi M; Chao Y; Zhao H; Anderson J; Cruz CD; Kudo M
    J Hepatol; 2019 Sep; 71(3):543-552. PubMed ID: 31176752
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.